Overview
Much progress has been made in managing and treating atopic dermatitis (AD) within the past few years. This 2-day conference will focus exclusively on AD and the complex information that has accrued around proper diagnosis, treatment, and management. Since its founding in 2019, Revolutionizing Atopic Dermatitis has become a fixture in dermatology, providing the highest-quality evidence-based and cutting-edge education in AD.
RAD is where your goal to improve patients’ lives harmonizes with meaningful discussions and groundbreaking concepts in atopic dermatitis. At this dynamic gathering, evidence drives the conversation, and strategies to step up care are conceived, giving you an unparalleled platform to expand your skills. Plus, this year, we’re turning up the energy in Nashville. Get ready to experience Nashville’s vibrant culture and iconic music scene while you update your knowledge and network with experts, right here at RAD!
Learning Objectives
- EVALUATE the efficacy, safety, and mechanisms of action of available treatments for AD, including biologics, JAK inhibitors, and topical therapies, while discussing emerging options in the pipeline.
- APPLY patient-centric approaches to AD management, incorporating disease severity, comorbidities, and patient preferences to optimize outcomes.
- REVIEW and implement guideline-directed care for AD, focusing on age-specific recommendations and treatment algorithms.
- UTILIZE effective communication techniques to improve patient adherence, manage expectations, and address concerns related to treatment options
Target Audience
This educational activity is designed for dermatologists, allergists, immunologists, pediatricians, primary care physicians, nurse practitioners, physician assistants, and other health care professionals involved in the diagnosis, management, and treatment of patients with atopic dermatitis.
Jonathan I. Silverberg, MD, PhD, MPH
Professor of Dermatology
Director of Clinical Research | Director of Patch Testing
The George Washington University School of Medicine and Health Sciences
Washington, DC, USA
Raj Chovatiya, MD, PhD, MSCI
Associate Professor, Rosalind Franklin University Chicago Medical School
Founder and Director, Center for Medical Dermatology and Immunology Research
Chicago, IL
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for Contact Hours.
A cancellation fee of 25% will be assessed on refunds requested 90 days before the start date, a 50% fee on refunds requested 60 days before the start date, and a 75% fee on refunds requested 30 days before the start date. No refunds will be made after 30 days before the start date. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.